Literature DB >> 7876661

Clinical and angiographic variables affecting the progression of coronary artery disease as determined by quantitative angiography.

A Joseph1, J D Talley, A Shih, T Crum, R Vogel, J Kupersmith.   

Abstract

To assess by serial quantitative angiography, the significance of clinical and angiographic variables that affect the progression of coronary artery disease (CAD). Progression of disease by sequential angiography is unpredictable and the role of clinical risk factors controversial. Various intervention trials have demonstrated less progression and even regression in hyperlipidemic patients. Correlates of progression have included a younger age, unstable angina, and greater involvement of the coronary arteries, with few studies looking at angiographic features of individual lesions. Serial angiograms on 74 patients were analyzed by computer assisted quantitative angiography using absolute measurements. A total of 99 diseased segments were analyzed for progression defined as an absolute reduction of 20% in luminal cross-sectional area. A preliminary correlation coefficient was calculated for each of the clinical and angiographic variables to detect any association with progression, and the odds ratio determined. The presence of any of the clinical risk factors-diabetes, hypertension, serum cholesterol, smoking, and a family history of coronary disease could not predict progression. The use of beta blockers was three times less likely to be associated with progression (odds ratio 0.33). While the presence of distal disease was associated with progression of a more proximal lesion (odds ratio 2.4), eccentricity, branch point location, lesion length, calcification, thrombus, or the presence of collaterals did not influence progression of disease in an individual segment. In conclusion, the presence of any of the clinical risk factors could not predict progression of disease in an individual coronary segment as determined by serial quantitative angiography, and the use of beta blockers and the absence of coexistent distal disease was associated with less progression of disease in an individual coronary segment. This may be related to changes in wall stress, reduced platelet interactions, and the integrity and permeability of the vascular endothelium to lipids.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7876661     DOI: 10.1007/bf01137903

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  41 in total

1.  A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association.

Authors:  W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

Review 2.  Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.

Authors:  N L Benowitz
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

3.  Effect of metoprolol on diet-induced atherosclerosis in rabbits.

Authors:  A M Ostlund-Lindqvist; P Lindqvist; J Bräutigam; G Olsson; G Bondjers; C Nordborg
Journal:  Arteriosclerosis       Date:  1988 Jan-Feb

4.  Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms.

Authors:  J H Reiber; P W Serruys; C J Kooijman; W Wijns; C J Slager; J J Gerbrands; J C Schuurbiers; A den Boer; P G Hugenholtz
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

5.  Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation.

Authors:  B G Brown; E Bolson; M Frimer; H T Dodge
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

6.  Sympathetic factors in the cardiovascular complications of hypertension: evidence in genetic models for hypertension, stroke and atherosclerosis.

Authors:  Y Yamori; Y Nara; M Mano; R Horie
Journal:  J Hypertens Suppl       Date:  1985-12

7.  Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analysis of 313 nonoperated patients.

Authors:  A Moise; J Lespérance; P Théroux; Y Taeymans; C Goulet; M G Bourassa
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778

8.  Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

Authors:  P R Lichtlen; P G Hugenholtz; W Rafflenbeul; H Hecker; S Jost; J W Deckers
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

9.  Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial.

Authors:  D Ornish; S E Brown; L W Scherwitz; J H Billings; W T Armstrong; T A Ports; S M McLanahan; R L Kirkeeide; R J Brand; K L Gould
Journal:  Lancet       Date:  1990-07-21       Impact factor: 79.321

10.  Inhibition of atherosclerosis associated with reduction of arterial intramural stress in rabbits.

Authors:  M J Thubrikar; J W Baker; S P Nolan
Journal:  Arteriosclerosis       Date:  1988 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.